{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:02:00Z","timestamp":1779339720673,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Foundation of President of Nanfang Hospital","award":["2020C039"],"award-info":[{"award-number":["2020C039"]}]},{"name":"The Foundation of President of Nanfang Hospital","award":["2020C033"],"award-info":[{"award-number":["2020C033"]}]},{"name":"The Foundation of President of Nanfang Hospital","award":["2020B012"],"award-info":[{"award-number":["2020B012"]}]},{"name":"The Foundation of President of Nanfang Hospital","award":["2020C006"],"award-info":[{"award-number":["2020C006"]}]},{"name":"Science and Technology Projects in Guangzhou, China","award":["202201010911"],"award-info":[{"award-number":["202201010911"]}]},{"name":"Science and Technology Projects in Guangzhou, China","award":["202206010045"],"award-info":[{"award-number":["202206010045"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82103595"],"award-info":[{"award-number":["82103595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82273564"],"award-info":[{"award-number":["82273564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Regional Joint Fund-Youth Fund Project","award":["2020A1515110006"],"award-info":[{"award-number":["2020A1515110006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s11010-023-04751-x","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T08:02:28Z","timestamp":1683187348000},"page":"629-642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2"],"prefix":"10.1007","volume":"479","author":[{"given":"Feng","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingdao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"4751_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4751_CR2","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMra2200869","volume":"386","author":"FA Sinicrope","year":"2022","unstructured":"Sinicrope FA (2022) Increasing incidence of early-onset colorectal cancer. N Engl J Med 386:1547\u20131558. https:\/\/doi.org\/10.1056\/NEJMra2200869","journal-title":"N Engl J Med"},{"key":"4751_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47600-y","author":"L Pastushok","year":"2019","unstructured":"Pastushok L, Fu Y, Lin L et al (2019) A novel cell-penetrating antibody Fragment inhibits the DNA repair protein RAD51. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-47600-y","journal-title":"Sci Rep"},{"key":"4751_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clcc.2014.11.002","volume":"14","author":"B Gustavsson","year":"2015","unstructured":"Gustavsson B, Carlsson G, Machover D et al (2015) A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer 14:1\u201310. https:\/\/doi.org\/10.1016\/j.clcc.2014.11.002","journal-title":"Clin Colorectal Cancer"},{"key":"4751_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000115967","volume":"81","author":"HR Mellor","year":"2008","unstructured":"Mellor HR, Callaghan R (2008) Resistance to chemotherapy in cancer: a complex and integrated cellular response. Pharmacology 81:275\u2013300. https:\/\/doi.org\/10.1159\/000115967","journal-title":"Pharmacology"},{"key":"4751_CR6","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1001\/jama.2011.749","volume":"305","author":"JJ Biagi","year":"2011","unstructured":"Biagi JJ, Raphael MJ, Mackillop WJ et al (2011) Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA 305:2335\u20132342. https:\/\/doi.org\/10.1001\/jama.2011.749","journal-title":"JAMA"},{"key":"4751_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/path.2780","volume":"222","author":"JW Jeuken","year":"2010","unstructured":"Jeuken JW, Wesseling P (2010) MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential. J Pathol 222:324\u2013328. https:\/\/doi.org\/10.1002\/path.2780","journal-title":"J Pathol"},{"key":"4751_CR8","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DTW Jones","year":"2008","unstructured":"Jones DTW, Kocialkowski S, Liu L et al (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673\u20138677. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2097","journal-title":"Cancer Res"},{"key":"4751_CR9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20949","author":"P Jain","year":"2017","unstructured":"Jain P, Silva A, Han HJ et al (2017) Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K\/mTOR signaling pathways. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.20949","journal-title":"Oncotarget"},{"key":"4751_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neo.2018.11.007","volume":"21","author":"R Chen","year":"2019","unstructured":"Chen R, Keoni C, Waker CA et al (2019) KIAA1549-BRAF expression establishes a permissive tumor microenvironment through NF\u03baB-mediated CCL2 production. Neoplasia 21:52\u201360. https:\/\/doi.org\/10.1016\/j.neo.2018.11.007","journal-title":"Neoplasia"},{"key":"4751_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2015.01.009","volume":"208","author":"A Kumar","year":"2015","unstructured":"Kumar A, Pathak P, Purkait S et al (2015) Oncogenic KIAA1549-BRAF fusion with activation of the MAPK\/ERK pathway in pediatric oligodendrogliomas. Cancer Genet 208:91\u201395. https:\/\/doi.org\/10.1016\/j.cancergen.2015.01.009","journal-title":"Cancer Genet"},{"key":"4751_CR12","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1101\/gad.200907.112","volume":"26","author":"A Kaul","year":"2012","unstructured":"Kaul A, Chen Y-H, Emnett RJ et al (2012) Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner. Genes Dev 26:2561\u20132566. https:\/\/doi.org\/10.1101\/gad.200907.112","journal-title":"Genes Dev"},{"key":"4751_CR13","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/neuonc\/nou059","volume":"16","author":"MA Karajannis","year":"2014","unstructured":"Karajannis MA, Legault G, Fisher MJ et al (2014) Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro-Oncol 16:1408\u20131416. https:\/\/doi.org\/10.1093\/neuonc\/nou059","journal-title":"Neuro-Oncol"},{"key":"4751_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1756-8722-7-8","volume":"7","author":"V Subbiah","year":"2014","unstructured":"Subbiah V, Westin SN, Wang K et al (2014) Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein. J Hematol OncolJ Hematol Oncol 7:8. https:\/\/doi.org\/10.1186\/1756-8722-7-8","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"4751_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s13167-019-00175-0","volume":"10","author":"N Li","year":"2019","unstructured":"Li N, Zhan X (2019) Identification of clinical trait\u2013related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer. EPMA J 10:273\u2013290. https:\/\/doi.org\/10.1007\/s13167-019-00175-0","journal-title":"EPMA J"},{"key":"4751_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41416-021-01306-z","volume":"125","author":"M Lin","year":"2021","unstructured":"Lin M, Fang Y, Li Z et al (2021) S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer. Br J Cancer 125:734\u2013747. https:\/\/doi.org\/10.1038\/s41416-021-01306-z","journal-title":"Br J Cancer"},{"key":"4751_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/pbc.25272","volume":"62","author":"M Antonelli","year":"2015","unstructured":"Antonelli M, Badiali M, Moi L et al (2015) KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis. Pediatr Blood Cancer 62:724\u2013727. https:\/\/doi.org\/10.1002\/pbc.25272","journal-title":"Pediatr Blood Cancer"},{"key":"4751_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/dnares\/7.4.271","volume":"7","author":"T Nagase","year":"2000","unstructured":"Nagase T (2000) Prediction of the coding sequences of unidentified Human GENES. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 7:271\u2013281. https:\/\/doi.org\/10.1093\/dnares\/7.4.271","journal-title":"DNA Res"},{"key":"4751_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.6004\/jnccn.2019.0044","volume":"17","author":"S Gupta","year":"2019","unstructured":"Gupta S, Provenzale D, Llor X et al (2019) NCCN guidelines insights: genetic\/Familial High-Risk assessment: colorectal, version 2.2019. J Natl Compr Cancer Netw JNCCN 17:1032\u20131041. https:\/\/doi.org\/10.6004\/jnccn.2019.0044","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"4751_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2009.24.8252","volume":"28","author":"S Kopetz","year":"2010","unstructured":"Kopetz S, Hoff PM, Morris JS et al (2010) Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance. J Clin Oncol Off J Am Soc Clin Oncol 28:453\u2013459. https:\/\/doi.org\/10.1200\/JCO.2009.24.8252","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"4751_CR21","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/cbic.201000724","volume":"12","author":"N Graf","year":"2011","unstructured":"Graf N, Ang WH, Zhu G et al (2011) Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin\/oxaliplatin cytotoxicity. ChemBioChem 12:1115\u20131123. https:\/\/doi.org\/10.1002\/cbic.201000724","journal-title":"ChemBioChem"},{"key":"4751_CR22","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1039\/d0mt00194e","volume":"12","author":"X Yuan","year":"2020","unstructured":"Yuan X, Zhang W, He Y et al (2020) Proteomic analysis of cisplatin- and oxaliplatin-induced phosphorylation in proteins bound to Pt-DNA adducts. Met Integr Biometal Sci 12:1834\u20131840. https:\/\/doi.org\/10.1039\/d0mt00194e","journal-title":"Met Integr Biometal Sci"},{"key":"4751_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1200\/JCO.1998.16.1.309","volume":"16","author":"R Metzger","year":"1998","unstructured":"Metzger R, Leichman CG, Danenberg KD et al (1998) ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol 16:309\u2013316. https:\/\/doi.org\/10.1200\/JCO.1998.16.1.309","journal-title":"J Clin Oncol"},{"key":"4751_CR24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ijc.20134","volume":"110","author":"C Welsh","year":"2004","unstructured":"Welsh C, Day R, McGurk C et al (2004) Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int J Cancer 110:352\u2013361. https:\/\/doi.org\/10.1002\/ijc.20134","journal-title":"Int J Cancer"},{"key":"4751_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1172\/JCI117388","volume":"94","author":"M Dabholkar","year":"1994","unstructured":"Dabholkar M, Vionnet J, Bostick-Bruton F et al (1994) Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. J Clin Invest 94:703\u2013708. https:\/\/doi.org\/10.1172\/JCI117388","journal-title":"J Clin Invest"},{"key":"4751_CR26","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1158\/1055-9965.EPI-06-0449","volume":"15","author":"SI Berndt","year":"2006","unstructured":"Berndt SI, Platz EA, Fallin MD et al (2006) Genetic variation in the nucleotide excision repair pathway and colorectal cancer risk. Cancer Epidemiol Prev Biomark 15:2263\u20132269. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0449","journal-title":"Cancer Epidemiol Prev Biomark"},{"key":"4751_CR27","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","volume":"22","author":"S Gurubhagavatula","year":"2004","unstructured":"Gurubhagavatula S, Liu G, Park S et al (2004) XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 22:2594\u20132601. https:\/\/doi.org\/10.1200\/JCO.2004.08.067","journal-title":"J Clin Oncol"},{"key":"4751_CR28","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4143\/crt.2015.098","volume":"48","author":"J Joo","year":"2016","unstructured":"Joo J, Yoon K-A, Hayashi T et al (2016) Nucleotide excision repair gene ERCC2 and ERCC5 variants increase risk of uterine cervical cancer. Cancer Res Treat 48:708\u2013714. https:\/\/doi.org\/10.4143\/crt.2015.098","journal-title":"Cancer Res Treat"},{"key":"4751_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lungcan.2015.05.001","volume":"89","author":"M-S Lee","year":"2015","unstructured":"Lee M-S, Liu C, Su L, Christiani DC (2015) Polymorphisms in ERCC1 and ERCC2\/XPD genes and carcinogen DNA adducts in human lung. Lung Cancer 89:8\u201312. https:\/\/doi.org\/10.1016\/j.lungcan.2015.05.001","journal-title":"Lung Cancer"},{"key":"4751_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00085","author":"E Boldrin","year":"2019","unstructured":"Boldrin E, Malacrida S, Rumiato E et al (2019) Association between ERCC1 rs3212986 and ERCC2\/XPD rs1799793 and OS in patients with advanced esophageal cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.00085","journal-title":"Front Oncol"},{"key":"4751_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1158\/1078-0432.CCR-18-1001","volume":"25","author":"Q Li","year":"2019","unstructured":"Li Q, Damish AW, Frazier Z et al (2019) ERCC2 helicase domain mutations confer nucleotide excision repair deficiency and drive cisplatin sensitivity in muscle-invasive bladder cancer. Clin Cancer Res 25:977\u2013988. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1001","journal-title":"Clin Cancer Res"},{"key":"4751_CR32","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0959-8049(98)00190-7","volume":"34","author":"G Damia","year":"1998","unstructured":"Damia G, Guidi G, D\u2019Incalci M (1998) Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines. Eur J Cancer 34:1783\u20131788. https:\/\/doi.org\/10.1016\/S0959-8049(98)00190-7","journal-title":"Eur J Cancer"},{"key":"4751_CR33","doi-asserted-by":"publisher","first-page":"53254","DOI":"10.18632\/oncotarget.10736","volume":"7","author":"H Zhao","year":"2016","unstructured":"Zhao H, Yu X, Ding Y et al (2016) MiR-770\u20135p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2. Oncotarget 7:53254\u201353268. https:\/\/doi.org\/10.18632\/oncotarget.10736","journal-title":"Oncotarget"},{"key":"4751_CR34","doi-asserted-by":"publisher","unstructured":"O\u2019Grady S, Finn SP, Cuffe S, Richard DJ, O\u2019Byrne KJ, Barr MP (2014) The role of DNA repair pathways in cisplatin resistant lung cancer. Cancer Treat Rev 40(10):1161\u201370. https:\/\/doi.org\/10.1016\/j.ctrv.2014.10.003","DOI":"10.1016\/j.ctrv.2014.10.003"},{"key":"4751_CR35","doi-asserted-by":"publisher","unstructured":"Weaver DA, Crawford EL, Warner KA, et al (2005) ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. Mol Cancer 4:18. https:\/\/doi.org\/10.1186\/1476-4598-4-18","DOI":"10.1186\/1476-4598-4-18"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04751-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04751-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04751-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T09:14:10Z","timestamp":1711185250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04751-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["4751"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04751-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Nanfang Hospital of Southern Medical University (NEFC-2022-367).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors read and approved the fnal manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}